Visit CONTRACT PHARMA at Booth 1361

Aptar Pharma’s Delivery System Approved for Santen Ophthalmic

03.25.19

Ophthalmic Squeeze Dispenser is an approved delivery system for eye disease treatment formulations without any preservatives

Aptar Pharma’s preservative-free multidose Ophthalmic Squeeze Dispenser has been approved for Santen’s prescription drug Taflotan/Saflutan for the reduction of elevated intraocular pressure (IOP) in e glaucoma and ocular hypertension, in 26 countries in Europe.
 
Aptar Pharma’s Ophthalmic Squeeze Dispenser is an approved delivery system for eye disease treatment formulations without any preservatives.
 
Aptar Pharma is working closely with leading global ophthalmology specialist Santen Pharmaceutical Co., Ltd. to improve patient safety, achieve dosing accuracy and maintain product integrity.
 
"We are delighted to launch preservative-free multi-dose formulations of these glaucoma therapies in Europe,” said Luis Iglesias, corporate officer and head of EMEA, Santen. “By providing highly effective and well-tolerated, preservative-free medicines, with the option for multi-dose bottles, we hope to empower patients in their daily lives and improve the management of their condition.”
 
Chemical preservatives are often used in eye drops to ensure sterility of the drops in multidose bottles. When used in short-term treatments, they are mostly well-tolerated. For long-term use, such as in chronic conditions that include dry eye and glaucoma, preservative-free products are preferred. Preservatives have been known to cause signs and symptoms of irritation, allergy and ocular surface toxicity.